Mission BioCapital

Mission BioCapital

Cambridge, Massachusettsmissionbiocapital.com

Overview

Mission BioCapital is a venture capital firm founded in 2009, focused on making pivotal early-stage investments in life sciences companies. The firm invests in therapeutics, diagnostics, medical devices, and drug delivery. It supports its portfolio companies through a unique model that combines capital investment with shared lab space and access to strategic partners via partnerships with incubators like MBC BioLabs and LabCentral. The firm has offices in Cambridge, MA, and San Francisco, CA.

Portfolio Companies

37

Investments

CompanyDateStageLead
Deck BioApr 2026SeedCo-investor
EpiBiologicsJan 2026Series BCo-investor
Enodia TherapeuticsJan 2026SeedCo-investor
Nocion TherapeuticsJan 2026Series B ExtensionCo-investor
AI ProteinsNov 2025Series ALead

Key People

Johannes Fruehauf

General Partner, Co-Founder

Peter Parker

Managing General Partner

Steve Tregay

Managing General Partner

Ulrik B. Nielsen

General Partner

Michael D Taylor

Operating Partner

Robert Blazej

Partner

Zach Collins

Partner

Cassidy Blundell

Principal

Chaya Patel

Principal

Clay Rowland

Investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCambridge, Massachusetts
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.